Description:Problem Statement
Cardiovascular diseases (CVDs) remain one of the leading causes of mortality worldwide, necessitating accurate and early detection for effective intervention. Traditional diagnostic methods, such as electrocardiograms (ECG) and echocardiography, rely on expert interpretation, making them susceptible to human error and inefficiencies. While machine learning models have shown promise in automating heart disease detection, a major challenge persists—imbalanced datasets. Typically, the number of healthy individuals significantly outweighs the number of patients with heart disease, leading to biased models that fail to correctly classify at-risk individuals.
Synthetic Minority Over-sampling Technique (SMOTE) is a commonly used method to address data imbalance; however, it introduces challenges like noise and overfitting. This research proposes an optimized SMOTE technique that enhances data quality and model generalization. Additionally, deep learning architectures, particularly Recurrent Neural Networks (RNNs), have demonstrated potential in analyzing time-series medical data. The proposed system leverages a Modified Gated Recurrent Unit (MGRU) combined with a Multi-Head Attention Mechanism (MHAM) to capture complex dependencies in medical records.
Furthermore, the integration of an Adaptive Regularized Extreme Learning Machine (ARELM) ensures efficient classification by minimizing overfitting and improving computational efficiency. By combining these advanced techniques—optimized SMOTE, MGRU-MHAM, and ARELM—the research aims to create a robust framework for early heart disease detection. This system improves diagnostic accuracy, balances data distribution, and enhances real-time applicability, ultimately aiding in timely medical intervention and improving patient outcomes.

C. EXISTING SOLUTIONS
Current heart disease detection methods primarily rely on traditional clinical assessments, such as electrocardiograms (ECG), echocardiography, and risk factor analysis. While these methods provide valuable insights, they require expert interpretation, making them prone to human error and inefficiencies. To overcome these limitations, machine learning-based models have been introduced to automate diagnosis and improve predictive accuracy.
Several prior studies have utilized conventional machine learning algorithms, including Support Vector Machines (SVM), Decision Trees, and Artificial Neural Networks (ANNs), to classify heart disease. However, these models often suffer from overfitting, lack generalization, and struggle with imbalanced datasets, where the number of healthy samples significantly outweighs diseased cases.
To mitigate data imbalance, techniques like Synthetic Minority Over-sampling Technique (SMOTE) have been employed. However, traditional SMOTE methods introduce synthetic noise and risk overfitting. Some studies have explored deep learning approaches, particularly Convolutional Neural Networks (CNNs) and Recurrent Neural Networks (RNNs), to extract features from medical time-series data. Despite their success, they often lack interpretability and computational efficiency.
Several patents exist on AI-driven heart disease prediction, focusing on ECG-based analysis, wearable monitoring systems, and deep learning algorithms. However, there is a gap in integrating optimized SMOTE, MGRU-MHAM, and ARELM to enhance data balance, feature extraction, and classification, making the proposed system a novel and effective solution.
1. List any known products, or combination of products, currently available to solve the same problem(s). What is the present commercial practice?
Ans.
Several AI-powered healthcare solutions exist for heart disease detection. Commercially available products include IBM Watson Health, Cardiologs, and AliveCor’s KardiaMobile, which use machine learning to analyze ECG signals for early detection. Wearable devices like Apple Watch and Fitbit also offer heart rate monitoring and arrhythmia detection.
Hospitals and clinics rely on ECG machines, echocardiograms, and Holter monitors for diagnosis, often combined with traditional risk assessments. AI-based decision support systems, such as those integrated into Philips IntelliSpace AI, assist doctors in predicting cardiac conditions. However, these systems lack an optimized framework combining SMOTE, MGRU-MHAM, and ARELM, limiting their predictive accuracy.
2. In what way(s) do the presently available solutions fall short of fully solving the problem?
Ans.
Current heart disease detection solutions face several limitations. Traditional methods like ECG and echocardiograms require expert interpretation, making them prone to human error. AI-based models, while promising, often struggle with imbalanced datasets, leading to biased predictions that overlook minority class patients. Conventional machine learning models, such as SVM and ANN, lack the ability to capture complex temporal dependencies in medical data. Deep learning approaches like CNNs and RNNs improve accuracy but can suffer from overfitting and poor interpretability. Existing commercial solutions also fail to integrate optimized SMOTE, MGRU-MHAM, and ARELM, limiting their efficiency in real-time early heart disease detection.
3. Conduct key word searches using Google and list relevant prior art material found?

1. Heart Disease Detection Using Machine Learning: This keyword helps identify research papers, patents, and commercial applications that focus on AI-driven methods for detecting heart disease. Relevant for exploring classification models like SVM, ANN, CNN, and RNN in healthcare.
2. Synthetic Minority Over-sampling Technique (SMOTE) in Medical Diagnosis: Focuses on studies and patents related to handling imbalanced datasets in medical applications using SMOTE and its optimized versions. Useful for finding prior work on improving data distribution for machine learning models.
3. Deep Learning for Cardiovascular Disease Prediction: Covers patents and academic research applying deep learning (GRU, LSTM, Attention Mechanisms) for time-series heart disease prediction. Helps in discovering architectures used in previous works.

4. Adaptive Regularized Extreme Learning Machine (ARELM) for Medical Data: Highlights prior applications of ARELM in medical data classification. Essential for understanding previous research on preventing overfitting and improving generalization.

5. AI-based ECG Analysis for Early Heart Disease Detection: Targets prior work on using AI to analyze ECG signals for early cardiac disease detection. Relevant for comparing commercial and patented ECG-based diagnostic tools.

D.DESCRIPTION OF PROPOSED INVENTION:
How does your idea solve the problem defined above? Please include details about how your idea is implemented and how it works?
The proposed invention introduces an advanced AI-driven system for early heart disease detection by integrating optimized SMOTE, Modified Gated Recurrent Unit (MGRU) with Multi-Head Attention Mechanism (MHAM), and Adaptive Regularized Extreme Learning Machine (ARELM). The optimized SMOTE technique addresses data imbalance, ensuring better model generalization. MGRU-MHAM enhances temporal feature extraction, improving interpretability and accuracy. ARELM minimizes overfitting and boosts computational efficiency, making real-time diagnosis feasible. This framework significantly improves heart disease prediction by overcoming challenges in existing models, offering a highly accurate, balanced, and efficient diagnostic tool, aiding early intervention, and enhancing patient outcomes in cardiovascular healthcare.
How the Idea Solves the Problem
1. Addresses Data Imbalance with Optimized SMOTE: Traditional heart disease prediction models suffer from imbalanced datasets, leading to biased classification. Optimized SMOTE generates high-quality synthetic samples while reducing noise and overfitting, improving the model’s ability to detect minority class (diseased) cases accurately.
2. Enhances Temporal Feature Extraction with MGRU-MHAM: Time-series medical data, such as ECG signals and patient health records, require models capable of capturing sequential dependencies. Modified Gated Recurrent Unit (MGRU) effectively retains long-term patterns, while Multi-Head Attention Mechanism (MHAM) selectively focuses on critical features, improving interpretability and precision.
3. Improves Classification Accuracy with ARELM: Traditional classifiers often overfit due to high-dimensional medical data. Adaptive Regularized Extreme Learning Machine (ARELM) dynamically adjusts regularization, ensuring robustness, reducing overfitting, and enabling fast real-time decision-making.
4. Enhances Generalization and Model Stability: Unlike conventional methods that struggle with unseen data, the integration of SMOTE, MGRU-MHAM, and ARELM ensures better generalization, making the system reliable across diverse datasets.
5. Facilitates Real-Time and Scalable Implementation: The model’s efficiency and computational speed make it suitable for real-time heart disease detection, assisting healthcare professionals in quick and accurate decision-making.
This innovative, AI-powered approach significantly enhances early diagnosis, improving patient outcomes and reducing cardiovascular mortality rates.

How the Framework Works
1. Data Preprocessing & Balancing with Optimized SMOTE: Raw medical data, including patient health records and ECG signals, is preprocessed for noise removal and normalization. Optimized SMOTE generates high-quality synthetic samples, addressing dataset imbalance and preventing biased learning.
2. Feature Extraction Using MGRU-MHAM: Modified Gated Recurrent Unit (MGRU) captures sequential dependencies in time-series data, enhancing temporal learning. Multi-Head Attention Mechanism (MHAM) selectively focuses on critical medical features, improving feature interpretability and classification accuracy.
3. Classification with Adaptive Regularized Extreme Learning Machine (ARELM): The extracted features are passed to ARELM, which dynamically adjusts regularization to reduce overfitting and improve generalization. The model ensures high-speed learning and efficient decision-making, making it suitable for real-time applications.
4. Prediction & Early Detection of Heart Disease: The system predicts whether a patient has heart disease based on optimized feature extraction and classification. The combination of MGRU-MHAM and ARELM improves sensitivity and specificity, enabling early and accurate detection.
5. Real-Time Implementation & Scalability: The framework is designed for real-time heart disease detection, enabling its deployment in hospitals, wearable devices, and telemedicine applications. Its high accuracy, adaptability, and efficiency make it a scalable solution for clinical and remote healthcare settings.

Applications and Benefits
Here are four key points highlighting the applications and benefits of the proposed system for early heart disease detection:
1. Improved Data Balance for Accurate Predictions: The system employs an optimized Synthetic Minority Over-sampling Technique (SMOTE) to address the issue of imbalanced datasets, ensuring better generalization and reducing biased predictions. This enhances the model’s ability to correctly identify patients at risk of heart disease.
2. Enhanced Feature Extraction and Interpretation: By integrating a Modified Gated Recurrent Unit (MGRU) with Multi-Head Attention Mechanism (MHAM), the system captures complex temporal dependencies in medical data. This allows for improved feature representation, helping the model focus on critical aspects of patient records for more precise diagnosis.
3. High-Speed and Efficient Classification: The Adaptive Regularized Extreme Learning Machine (ARELM) improves classification accuracy by dynamically adjusting regularization parameters. This prevents overfitting while maintaining computational efficiency, making the system suitable for real-time heart disease detection.
4. Better Early Detection and Patient Outcomes: The combination of optimized SMOTE, MGRU-MHAM, and ARELM provides a highly accurate, scalable, and reliable diagnostic tool. This enables timely medical intervention, reducing the risk of severe cardiovascular complications and ultimately improving patient care and survival rates.
E. NOVELTY:
The proposed system uniquely integrates an optimized Synthetic Minority Over-sampling Technique (SMOTE), Modified Gated Recurrent Unit with Multi-Head Attention Mechanism (MGRU-MHAM), and Adaptive Regularized Extreme Learning Machine (ARELM) to enhance heart disease detection by effectively addressing data imbalance, improving feature extraction, and ensuring high-speed, accurate classification, surpassing traditional machine learning models in sensitivity and real-time applicability.
F. COMPARISON:
The proposed system for early heart disease detection integrates Optimized SMOTE, Modified Gated Recurrent Unit with Multi-Head Attention Mechanism (MGRU-MHAM), and Adaptive Regularized Extreme Learning Machine (ARELM) to overcome the challenges faced by traditional models. Below is a detailed comparison highlighting the key differences and advantages over previous solutions:
1. Data Imbalance Handling
Traditional Solutions:
• Conventional machine learning models often suffer from imbalanced datasets, where the number of healthy samples significantly outweighs diseased cases.
• Traditional SMOTE (Synthetic Minority Over-sampling Technique) is widely used but introduces noise and overfitting, leading to unreliable synthetic samples.
Proposed Solution:
• Uses an Optimized SMOTE technique that refines the synthetic sample generation process to reduce noise and overfitting.
• Enhances the representation of minority class data, ensuring better generalization and higher sensitivity to early-stage heart disease cases.
• This leads to improved classification accuracy, particularly in detecting underrepresented diseased cases.

2. Feature Extraction and Temporal Dependency Analysis
Traditional Solutions:
• Many existing heart disease detection models rely on shallow machine learning models (e.g., SVM, Decision Trees, Random Forest), which fail to capture sequential dependencies in medical time-series data (such as ECG signals).
• Traditional deep learning models, such as standard GRU or LSTM, do not always effectively focus on the most critical features of input data.

Proposed Solution:
• Introduces Modified Gated Recurrent Unit (MGRU) with Multi-Head Attention Mechanism (MHAM), which enhances feature selection and temporal analysis.
• MGRU improves the model’s ability to capture long-term dependencies in sequential medical data, making it particularly effective for analyzing patient records over time.
• Multi-Head Attention Mechanism (MHAM) selectively focuses on the most relevant data features, improving both model interpretability and prediction accuracy.
• This allows the system to extract more meaningful patterns from medical datasets, leading to superior diagnostic performance.

3. Classification Accuracy and Overfitting Prevention
Traditional Solutions:
• Common classification techniques, such as Extreme Learning Machines (ELM) and Support Vector Machines (SVM), often struggle with overfitting and poor generalization, especially when dealing with imbalanced datasets.
• Conventional ELM lacks dynamic regularization, making it prone to biased predictions in real-world medical applications.
Proposed Solution:
• Integrates Adaptive Regularized Extreme Learning Machine (ARELM), which dynamically adjusts regularization parameters to prevent overfitting.
• ARELM ensures a faster training process while maintaining high accuracy, making it suitable for real-time diagnostic applications.
• Unlike traditional classifiers, ARELM significantly improves generalization performance, enabling it to handle high-dimensional medical data with minimal computational cost.
4. Computational Efficiency and Real-Time Application
Traditional Solutions:
• Many deep learning-based models require high computational resources, making them difficult to deploy in real-time clinical settings.
• Standard machine learning models lack the ability to handle large-scale medical datasets efficiently.
Proposed Solution:
• The combination of Optimized SMOTE, MGRU-MHAM, and ARELM results in a highly computationally efficient framework.
• ARELM’s high-speed learning capability reduces training time, making the system practical for real-time heart disease detection.
• The proposed system is scalable and can be implemented in cloud-based or edge-computing healthcare applications.

5. Overall Diagnostic Reliability and Early Detection
Traditional Solutions:
• Traditional heart disease detection models often suffer from low sensitivity in detecting early-stage cardiovascular diseases.
• Existing methods may provide delayed or less accurate diagnoses, leading to missed early interventions.
Proposed Solution:
• By integrating optimized data balancing, advanced feature extraction, and adaptive classification, the proposed system significantly improves early detection rates.
• The system provides highly interpretable results, aiding healthcare professionals in making timely and accurate clinical decisions.
• Improved sensitivity and specificity contribute to better patient outcomes and reduced cardiovascular complications.

Summary of Advantages
Feature Traditional Solutions Proposed Solution
Data Imbalance Handling Basic SMOTE (prone to noise, overfitting) Optimized SMOTE (high-quality synthetic data, better generalization)
Feature Extraction Limited to shallow ML models or basic GRU/LSTM MGRU-MHAM (enhanced sequential dependency analysis)
Attention Mechanism Absent or single-head attention Multi-Head Attention Mechanism (MHAM) for improved feature selection
Classification Model Standard ELM, SVM (prone to overfitting, lacks adaptability) Adaptive Regularized Extreme Learning Machine (ARELM) for robust classification
Computational Efficiency High resource demand, not suitable for real-time applications Faster learning, scalable for real-time use
Early Detection Capability Low sensitivity in detecting early-stage heart disease High accuracy, early-stage detection, better patient outcomes
, Claims:We Claim
1. We claim that the proposed system enhances heart disease detection accuracy by integrating an optimized Synthetic Minority Over-sampling Technique (SMOTE) to address data imbalance, ensuring improved generalization and reducing the risk of biased predictions.
2. We claim that the incorporation of a Modified Gated Recurrent Unit (MGRU) with a Multi-Head Attention Mechanism (MHAM) improves feature extraction from sequential medical data, enabling the model to focus on critical patterns and dependencies for more precise diagnosis.
3. We claim that the use of an Adaptive Regularized Extreme Learning Machine (ARELM) for classification enhances model generalization by dynamically adjusting regularization parameters, preventing overfitting while maintaining computational efficiency and high-speed learning.
4. We claim that the combination of optimized SMOTE, MGRU-MHAM, and ARELM provides a novel and robust framework for early heart disease detection, outperforming traditional machine learning models in terms of sensitivity, specificity, and real-time applicability.
5. We claim that the system’s ability to effectively balance datasets, extract meaningful temporal features, and classify patients with high accuracy makes it a reliable and scalable diagnostic tool, contributing to early intervention and improved patient outcomes in cardiovascular healthcare.